+------------------------------------------------------------------------------+
Pfizer CEO Read Admires Glaxo, Could Also Consider Actavis: FT 2015-01-21 17:33:09.154 GMT
By Robin Stringer (Bloomberg) -- CEO Ian Read admires GlaxoSmithKline, FT says, citing 1 person familiar w/ his thinking. * Pfizer, which tried to invert by buying U.K.-domiciled AstraZeneca, has tax rate of ~27% * Read has said there are still some advantages of doing an inversion despite crackdown, FT says * Pfizer could also consider buying Actavis if co. stops expanding, FT cites unidentified health-care bankers as saying * Pfizer declined to comment to FT * NOTE: Aug. 1, Glaxo Market Cap Slump May Interest Pfizer: Berenberg Link * Nov. 26, Mylan Most Likely Pfizer Target, Glaxo Is ‘Wild Card’: Jefferies Link Link to Story: http://on.ft.com/1umebfI
Link to Company News:PFE US <Equity> CN <GO> Link to Company News:GSK LN <Equity> CN <GO> Link to Company News:ACT US <Equity> CN <GO>
For Related News and Information: First Word scrolling panel: FIRST<GO> First Word newswire: NH BFW<GO>
To contact the editor responsible for this story: Robin Stringer at +1-212-617-2526 or rstringer7@bloomberg.net